<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pmj-1646</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PUBLIC HEALTH ORGANIZATION</subject></subj-group></article-categories><title-group><article-title>ИСПОЛЬЗОВАНИЕ ПОЭТАПНОГО КАЛЬКУЛИРОВАНИЯ В ОПТИМИЗАЦИИ РАБОТЫ АПТЕКИ СОВМЕСТНОГО ПРЕДПРИЯТИЯ</article-title><trans-title-group xml:lang="en"><trans-title>THE USAGE OF STEP CONTRIBUTION REPORTING METHOD IN OPTIMIZATION OF PHARMACY PERFORMANCE OF JOINT VENTURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеева</surname><given-names>Н. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Yeliseeva</surname><given-names>N. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хабаровск;</p><p>Южно-Сахалинск</p><p> </p></bio><bio xml:lang="en"><p>Khabarovsk;</p><p>Yuzhno-Sakhalinsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Дальневосточный государственный медицинский университет;&#13;
Аптека «Эй И Эй Интернэшнл (Сахалин) ЗАО»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Far-Eastern State Medical University;&#13;
Pharmacy ZAO «AEA International (Sakhalin) ZAO»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2006</year></pub-date><volume>0</volume><issue>4</issue><fpage>82</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Елисеева Н.И., 2006</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="ru">Елисеева Н.И.</copyright-holder><copyright-holder xml:lang="en">Yeliseeva N.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/1646">https://www.tmj-vgmu.ru/jour/article/view/1646</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>The nowadays situation of market relations development in Russia’s economy, bring forward a number of problems in pharmaceutical enterprises’ performance, connected with the importance of providing their competitiveness. Given that the choice of strategic development with account of internal and external environment, within which the enterprise operates, gains the most important significance. The technique of competitiveness assessment, based on the procedures of indicative analysis, including the step contribution reporting is applied nowadays. The usage of step contribution reporting provides an opportunity to perform profitability analysis of special kinds of drugs’ items, as well as assortment of pharmaceutical production from target groups’ profitability point of view, and respectively, being geared to marketing research, to work out assortment policy of enterprise, catering on its development.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>совместное предприятие</kwd><kwd>аптека</kwd><kwd>модель</kwd><kwd>управление ассортиментом</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Басок А.В., Мартиросян А.С. // Менеджер. – 2002. – № 5. – С. 71–78.</mixed-citation><mixed-citation xml:lang="en">Басок А.В., Мартиросян А.С. // Менеджер. – 2002. – № 5. – С. 71–78.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева О. // Корпоративные системы. – 2000. – № 4. – С. 22–26.</mixed-citation><mixed-citation xml:lang="en">Васильева О. // Корпоративные системы. – 2000. – № 4. – С. 22–26.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Доклады Территориального органа Федеральной службы госстатистики по Сахалинской области «Социально-экономическое положение Сахалинской области в 2004–2005 гг.». – Южно-Сахалинск, 2005.</mixed-citation><mixed-citation xml:lang="en">Доклады Территориального органа Федеральной службы госстатистики по Сахалинской области «Социально-экономическое положение Сахалинской области в 2004–2005 гг.». – Южно-Сахалинск, 2005.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кобина С.А. // Ремедиум. – 1999. – № 4. – С. 38–44.</mixed-citation><mixed-citation xml:lang="en">Кобина С.А. // Ремедиум. – 1999. – № 4. – С. 38–44.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Котлер Ф. Маркетинг-менеджмент / пер. с англ. – СПб. : Питер Ком, 1999.</mixed-citation><mixed-citation xml:lang="en">Котлер Ф. Маркетинг-менеджмент / пер. с англ. – СПб. : Питер Ком, 1999.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Краснокутский А.Б., Лагунова А.А. Фармаэкономика. – Т. 1. [Системный анализ мирового фармацевтического рынка]. – М. : Классик-Консалтинг, 1998.</mixed-citation><mixed-citation xml:lang="en">Краснокутский А.Б., Лагунова А.А. Фармаэкономика. – Т. 1. [Системный анализ мирового фармацевтического рынка]. – М. : Классик-Консалтинг, 1998.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Мнушко З.Н., Евтушенко Е.Н. // Провизор. – 2004. – № 20. – С. 5–8.</mixed-citation><mixed-citation xml:lang="en">Мнушко З.Н., Евтушенко Е.Н. // Провизор. – 2004. – № 20. – С. 5–8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Паршина Н.И., Ветютнева Н.А. // Фармацевтический журнал. – 2003. – № 5. – С. 3–6.</mixed-citation><mixed-citation xml:lang="en">Паршина Н.И., Ветютнева Н.А. // Фармацевтический журнал. – 2003. – № 5. – С. 3–6.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell D., Cerasa D., Williams J. International SOS Pharmacy Service SOPP. – Singapore : SOS CIS Region Pharmacy Management Committee, 2002.</mixed-citation><mixed-citation xml:lang="en">Campbell D., Cerasa D., Williams J. International SOS Pharmacy Service SOPP. – Singapore : SOS CIS Region Pharmacy Management Committee, 2002.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
